NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
11 trialsNCT04751370 2026-03-18
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04929028 2026-03-18
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT05630794 2026-03-18
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT03955510 2025-10-28
AFT
Rush University Medical Center
Phase NA Active not recruiting
NCT01696981 2025-07-23
Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
NCT06780787 2025-06-26
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
City of Hope Medical Center
Phase 2 Recruiting
NCT00927485 2020-12-16
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
University of Puerto Rico
Phase NA Completed
NCT00893295 2013-12-18
Increasing Colorectal Cancer Screening in African Americans
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00960427 2013-04-16
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn
NCT01767870 2013-01-14
FITS
Yonsei University
Phase 4 Unknown